ÂÜÀòÂÒÂ×

Dr. Adams brings with him a wealth of expertise in successfully developing and bringing medical devices to global markets. He is currently a Director and Chief Executive Officer of VentriPoint Diagnostics Ltd. (TSXV: VPT). Dr. Adams is a scientist and a serial entrepreneur with extensive public market experience. His previous positions include CEO of Amorfix Life Sciences (TSX: AMF), Chairman of Sernova Corp (TSXV: SVA) and President and CEO of the UT Innovations Foundation. Prior to this, he held research and executive positions with Boston Scientific Inc, Pfizer Inc, Corvita Canada Inc., University of Ottawa, and the Canadian Red Cross. He has been instrumental in founding over 32 companies that have raised $120 million and has been a Director of 10 venture capital funds, 10 start-up companies, and two Centres of Excellence. Dr. Adams was awarded a World Economic Foundation Technology Pioneer for 2007 and TBI Company of the year in 2009. Dr. Adams has 124 scientific publications and is a reviewer for major scientific journals, federal granting agencies, and Centres of Excellence. Dr. Adams obtained his BASc and MASc from the University of Waterloo and his Ph.D. in Blood and Cardiovascular Disease, from McMaster University.